Role of delay discounting in predicting change in HBA1c for individuals with prediabetes

J Behav Med. 2019 Oct;42(5):851-859. doi: 10.1007/s10865-019-00026-3. Epub 2019 Mar 22.

Abstract

The majority of people with prediabetes transition to type 2 diabetes. Weight gain is a known predictor of increasing the risk of diabetes, but another reason may be a focus on immediate rewards and discounting of the future. Delay discounting (DD: devaluation of future consequences) is related to obesity and poor glycemic control in persons with type 2 diabetes. This study was designed to assess whether changes in DD are associated with HbA1c change beyond BMI change in individuals with prediabetes. Hierarchical regression showed changes in BMI (p = 0.008) and the $1000 DD task (p = 0.04) were associated with HbA1c change beyond demographic characteristics, with the full model accounting for 25.8% of the variance. Those with greater BMI increases and greater increases in discounting of the future showed the greatest increases in HbA1c. DD represents a novel target to prevent progression from prediabetes to type 2 diabetes.

Keywords: Delay discounting; Glycemic control; Prediabetes.

MeSH terms

  • Body Mass Index
  • Delay Discounting*
  • Disease Progression
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Obesity / complications
  • Prediabetic State / metabolism*
  • Prediabetic State / psychology*
  • Predictive Value of Tests

Substances

  • Glycated Hemoglobin A